Page results
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Information covering a range of conditions. Search by condition name or condition type (specialty).
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
-
Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.
-
In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.
-
This page provides information for pregnant women with Inflammatory Bowel Disease.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
File results
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0509 - Immunoglobulin treatments